Dow Up 1.13% Nasdaq Up 1.41%

Immunomedics Inc. (IMMU)

-NasdaqGM
3.95 Down 0.05(1.25%) Oct 31, 4:00PM EDT
|After Hours : 3.95 Up 0.00 (0.01%) Oct 31, 4:43PM EDT
Prev Close:4.00
Open:4.11
Bid:N/A
Ask:4.11 x 1000
1y Target Est:6.33
Beta:0.25
Next Earnings Date:N/A
Day's Range:3.94 - 4.15
52wk Range:3.04 - 6.17
Volume:849,197
Avg Vol (3m):653,159
Market Cap:367.80M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMU

Comparison

Symbol% ChgMkt Cap
IMMUDown 1.25%367.80M
BIIBUp 0.02%75.82B
GSKUp 0.78%109.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):41.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.46
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback